EPS Bio Technology Corp. (TPEX:4183)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
16.00
0.00 (0.00%)
Feb 10, 2026, 12:18 PM CST
Market Cap380.80M -31.6%
Revenue (ttm)497.19M +2.5%
Net Income-14.24M
EPS-0.60
Shares Out23.80M
PE Ration/a
Forward PEn/a
Dividend0.67 (4.19%)
Ex-Dividend DateAug 28, 2025
Volume2,000
Average Volume14,785
Open16.00
Previous Close16.00
Day's Range16.00 - 16.00
52-Week Range15.65 - 23.40
Beta0.17
RSI40.45
Earnings DateMar 11, 2026

About EPS Bio Technology

EPS Bio Technology Corp. manufactures and sells OEM/ODM blood glucose system in Taiwan. It also provides test strip; diabetic self-monitoring blood glucose systems under the EASYMAX and MDT2 BLE name; and wearable, and NFC and Bluetooth connectivity blood glucose monitors. The company was founded in 2006 and is headquartered in Hsinchu City, Taiwan. [Read more]

Sector Healthcare
Founded 2006
Employees 109
Stock Exchange Taipei Exchange
Ticker Symbol 4183
Full Company Profile

Financial Performance

In 2024, EPS Bio Technology's revenue was 451.08 million, a decrease of -4.06% compared to the previous year's 470.17 million. Earnings were 17.31 million, a decrease of -17.54%.

Financial Statements